FDA Device Intelligence
HomeAP MDS Co., Ltd. › 2Way Foley Balloon Catheter

2Way Foley Balloon Catheter

AP MDS Co., Ltd. · Model APO-FC-012 · UDI-DI 08800109201528

EZL
1
510(k) clearances
9,331
Adverse events (12 deaths)
84
Recalls
115
Facilities

Description

This product is a Foley Balloon Catheter commonly used in urology. It is consisting of a Manifold part and a Shaft parts. The Manifold Parts is equipped with a non-return valve for inflate the balloon and a band to fix the non-return valve and to identify the catheter’s size by color. The Shaft parts has an x-ray opaque line for check to position and balloon for located the catheter in the bladder, a drainage eye for urine drainage, and a rounded tip for easy insertion of the shaft. The proposed device is supplied in French size ranging from 12 to 24. It is available in 337(±15) and 345(±15) mm length with various balloon sizes. The devices are applied for adults only.

Recalls

DateFirmReason
2026-04-23C.R. Bard IncDue to stain present on the surface of affected foley catheters.
2025-06-18C.R. Bard IncFoley catheter may have an obstructed lumen, which may result in an inability to drain the bladder, of urine and may include pelvic or abdominal pain, flank pain, bladder dysfuncti
2024-12-02Coloplast Manufacturing US, LLCA possible sterility issue was detected in Coloplast's facility on some Coloplast products.
2024-12-02Coloplast Manufacturing US, LLCA possible sterility issue was detected in Coloplast's facility on some Coloplast products.
2023-12-04Cardinal Health 200, LLCConvenience kits were manufactured and distributed with components which were subsequently recalled by Nurse Assist.
2023-11-06Nurse Assist, LLCSodium chloride irrigation USP, and sterile water for irrigation USP, that may be packaged inside kits, have the potential for a lack of sterility assurance, which could result in
2021-08-05C.R. Bard IncThere is potential for packaging defects that may impact the sterile barrier.
2021-08-05C.R. Bard IncThere is potential for packaging defects that may impact the sterile barrier.
2021-08-05C.R. Bard IncThere is potential for packaging defects that may impact the sterile barrier.
2021-08-05C.R. Bard IncThere is potential for packaging defects that may impact the sterile barrier.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.